weight loss pills

Drug and medical-device maker Abbott Laboratories announced Friday that it will voluntarily withdraw its controversial obesity drug Meridia, (sibutramine) from the U.S. market at the request of the FDA, due to concerns it increases the risk of heart attacks and strokes.

The N.J. Supreme Court gave a win to advocates of truth in advertising this week when it ruled that lawsuits against the maker of dietary supplement Relacore could go forward as a class action. Considering the way such lawsuits work, gaining that status is almost as important as the final verdict.

The New England Journal of Medicine called Meridia "another flawed diet pill" -- two weeks before government advisers are scheduled to review the drug -- after a study finds it raises the risk of heart attack and stroke in users with heart problems.

Every day, WalletPop will be bringing you information about a fantastic freebie. Like what you see? Check back tomorrow for more!Wal-Mart giving away a book? Has the Grinch found religion? But if you click here and then click on "get the book free", you can get started on the "alli" program today....